J Natl Compr Canc Netw. 2022 Jun 2;20(5.5):1-4. doi: 10.6004/jnccn.2022.5025.
Although many people with cancer have benefited from the host of therapeutic and research advances across many different tumor types over the past decades. Not every patient with cancer is afforded the opportunity for such treatments, and there is an assortment of notable barriers to the delivery of equitable care for all. To address the complexity of this important issue in contemporary cancer care, a distinguished panel at the NCCN 2022 Annual Conference explored this topic from several different vantage points, including the patient perspective and the view from inside the LGBTQ+ community. In addition, several panel members explored the constructive steps and initiatives being taken in the clinical, research, and policy realms to improve access to care for all patients with cancer, as well as overall health equity.
尽管在过去几十年中,许多癌症患者受益于众多不同肿瘤类型的治疗和研究进展。但并非每个癌症患者都有机会接受此类治疗,而且在为所有人提供公平护理方面存在一系列显著障碍。为了解决当代癌症护理中这一重要问题的复杂性,NCCN 2022 年年会的一个杰出小组从多个不同角度探讨了这一主题,包括患者视角和 LGBTQ+群体的观点。此外,几位小组成员还探讨了在临床、研究和政策领域正在采取的建设性步骤和举措,以改善所有癌症患者的护理机会,并提高整体健康公平性。